No Picture
News

Twist Bioscience’s ‘Factory of the Future’ in Oregon could deliver with competitive pricing, SVB Securities says

The synthetic DNA manufacturer Twist Bioscience has given a peek behind the curtain to several analysts into its “Factory of the Future” as well as insight into the cost structure, workflow and technology at the […]

No Picture
News

Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive

MONTPELLIER, France–(BUSINESS WIRE)–MedinCell (Paris:MEDCL) has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to […]

No Picture
News

UTMB and HDT Bio awarded prototype project funding worth up to $87.4M from the U.S. government to develop saRNA vaccine technology

GALVESTON, Texas & SEATTLE–(BUSINESS WIRE)–Two deadly viruses significant to the military to be targets for vaccine protection: Crimean-Congo hemorrhagic fever virus and Nipah virus. Click here to view original post

No Picture
News

Iodine Deficiency Drug Market to Garner USD 6.5 Billion, Globally, by 2031 at 5.8% CAGR: Allied Market Research

Rise in prevalence of hypothyroidism in geriatric populations, surge in hypothyroidism in children, and education on iodine deficiency disorders have boosted the growth of the global iodine deficiency drug market. PORTLAND, Ore., Nov. 30, 2022 […]

No Picture
News

Aurion Biotech Expands Its Leadership Team

SEATTLE, BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as vice president, clinical operations and Sterling […]

No Picture
News

Seattle Startup with Fresh Approach to Parkinson’s and Alzheimer’s Disease Raises $96M

Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed more details about its strategy and announced $96M in funding. Biopharma companies have spent billions […]